Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Anu Kutila"'
Autor:
Timo Siitonen, Timo Timonen, Eeva Juvonen, Venla Terävä, Anu Kutila, Tuomo Honkanen, Maija Mikkola, Heikki Hallman, Marjut Kauppila, Pirkko Nyländen, Eira Poikonen, Auvo Rauhala, Marjatta Sinisalo, Merja Suominen, Eeva-Riitta Savolainen, Pirjo Koistinen
Publikováno v:
Haematologica, Vol 92, Iss 8 (2007)
Valproic acid (VPA), an inhibitor of histone deacetylases, inhibits the growth of leukemia cells and induces their differentiation in vitro. In the present study, VPA in combination with two differentiating agents, 13-cis retinoic acid and 1,25-dihyd
Externí odkaz:
https://doaj.org/article/9c3c31a9b98443a3a4d3779322544994
Autor:
Ville, Varmavuo, Johanna, Rimpiläinen, Hanne, Kuitunen, Anne, Nihtinen, Kaija, Vasala, Maija, Mikkola, Anu, Kutila, Päivi, Lehtonen, Taru, Kuittinen, Pentti, Mäntymaa, Tapio, Nousiainen, Outi, Kuittinen, Esa, Jantunen
Publikováno v:
Transfusion. 54(5)
Plerixafor is used in combination with granulocyte-colony-stimulating factor to enhance the mobilization of hematopoietic stem cells. Limited data are available in regard to effects of plerixafor on posttransplant outcomes in chemomobilized patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4de8dc66e8d95381d926e4310a039468
https://pubmed.ncbi.nlm.nih.gov/24118008
https://pubmed.ncbi.nlm.nih.gov/24118008
Autor:
Anu Kutila, Tuomo Honkanen, Pirjo Koistinen, Maija Mikkola, Marjut Kauppila, Heikki Hallman, Timo Timonen, Eeva-Riitta Savolainen, Pirkko Nyländen, Eira Poikonen, Venla Terävä, Auvo Rauhala, Merja Suominen, Timo Siitonen, Marjatta Sinisalo, Eeva Juvonen
Publikováno v:
Haematologica. 92(8)
Valproic acid (VPA), an inhibitor of histone deacetylases, inhibits the growth of leukemia cells and induces their differentiation in vitro. In the present study, VPA in combination with two differentiating agents, 13-cis retinoic acid and 1,25-dihyd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc6a74340f769b058ee151930e80b92b
https://pubmed.ncbi.nlm.nih.gov/17650442
https://pubmed.ncbi.nlm.nih.gov/17650442
Autor:
Jaakko Valtola, Esa Jantunen, Taru Kuittinen, Marja Pyörälä, Anne Nihtinen, Antti Ropponen, Ville Varmavuo, Tapio Nousiainen, Jukka Pelkonen, Anu Kutila, Karri Penttilä, Päivi Lehtonen, Kaija Vasala, Pekka Mäntymaa
Publikováno v:
Blood. 124:1193-1193
Introduction: Plerixafor, a reversible CXCR4 antagonist, may be used to enhance mobilization of CD34+ cells after G-CSF or chemotherapy plus G-CSF. There is a paucity of prospective data regarding cellular composition of grafts collected after plerix
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93a9185414fb7479d4fdec03573d9714
https://doi.org/10.1182/blood.v124.21.1193.1193
https://doi.org/10.1182/blood.v124.21.1193.1193
Autor:
Venla Terävä, Anu Sikiö, Raija Silvennoinen, Piotr Bazia, Marjaana Säily, Timo Siitonen, Taru Kuittinen, Kirsi Launonen, Kimmo Porkka, Pekka Anttila, Mari Partio, Sakari Kakko, Mervi Putkonen, Esa Jantunen, Merja Suominen, Seppo Vanhatalo, Kari Remes, Anu Räsänen, Anu Kutila, J Heiskanen, Hanna Ollikainen, Kristiina Kananen, Tuija Lundán
Publikováno v:
Blood. 124:847-847
Introduction Autologous stem cell transplantation (ASCT) is the standard treatment in multiple myeloma (MM) for eligible patients below 70 years of age. The main mobilization treatment in Europe consists of combination of cyclophosphamide (CY) and G-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94ab06ec2dd0c39383d59f8ffe99d691
https://doi.org/10.1182/blood.v124.21.847.847
https://doi.org/10.1182/blood.v124.21.847.847